Francisco Osvaldo García-Pérez (Francisco García-Pérez, Francisco Osvaldo García Pérez, Osvaldo García-Pérez)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Combination Therapy

Molecular Docking

Positron Emission Tomography

Top Venues

Pharmaceuticals (Basel, Switzerland)

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Pedro Cruz-Nova, Myrna Luna-Gutiérrez, Gerardo Bravo-Villegas, Erika Azorín-Vega, Nallely Jiménez-Mancilla, Emiliano Michel-Sánchez, Francisco Osvaldo García-Pérez, Nancy Lara-Almazán, Clara Leticia Santos Cuevas
99m Tc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe. Pharmaceutics 15 (12) (2023)
Joel E Vargas-Ahumada, Sofía Denisse González-Rueda, Fabio Andrés Sinisterra-Solís, Pamela Casanova-Triviño, Quetzali Pitalúa-Cortés, Irma Soldevilla-Gallardo, Anna Scavuzzo, Miguel Angel Jimenez-Ríos, Francisco Osvaldo García-Pérez
Diagnostic Performance of 99m Tc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18 F-PSMA-1007 PET/CT. Cancers 15 (24) (2023)
Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Pedro Cruz-Nova, Myrna Luna-Gutiérrez, Gerardo Bravo-Villegas, Erika Azorín-Vega, Nallely Jiménez-Mancilla, Emiliano Michel-Sánchez, Francisco Osvaldo García-Pérez, Nancy Lara-Almazán, Clara Leticia Santos Cuevas
99m Tc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe. Pharmaceutics 15 (12) (2023)
Myrna Luna-Gutiérrez, Rodrigo Hernández-Ramírez, Airam Soto-Abundiz, Francisco Osvaldo García-Pérez, Alejandra Ancira-Cortez, Sergio López-Buenrostro, Brenda Gibbens-Bandala, Irma Soldevilla-Gallardo, Nancy Lara-Almazán, Melissa Rojas-Pérez, Blanca Ocampo-Garcia, Erika Azorín-Vega, Clara Leticia Santos Cuevas, Guillermina Ferro-Flores
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177 Lu-iPSMA and 177 Lu-DOTATOC: Experience after 905 Treatment Doses. Pharmaceutics 15 (7) (2023)
Joel E Vargas-Ahumada, Sofía Denisse González-Rueda, Fabio Andrés Sinisterra-Solís, Pamela Casanova-Triviño, Quetzali Pitalúa-Cortés, Irma Soldevilla-Gallardo, Anna Scavuzzo, Miguel Angel Jimenez-Ríos, Francisco Osvaldo García-Pérez
Diagnostic Performance of 99m Tc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18 F-PSMA-1007 PET/CT. Cancers 15 (24) (2023)
Joel Vargas Ahumada, Sofía D González Rueda, Fabio Andrés Sinisterra-Solís, Quetzali Pitalúa Cortés, Liliana P Torres Agredo, Jimenez Ríos Miguel, Anna Scavuzzo, Irma Soldevilla-Gallardo, Miguel A Álvarez Avitia, Nora Sobrevilla, Francisco Osvaldo García-Pérez
Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation. Diagnostics (Basel, Switzerland) 12 (6) (2022)
Paola Vallejo-Armenta, Guillermina Ferro-Flores, Clara Leticia Santos Cuevas, Francisco Osvaldo García-Pérez, Pamela Casanova-Triviño, Bayron Sandoval-Bonilla, Blanca Ocampo-Garcia, Erika Azorín-Vega, Myrna Luna-Gutiérrez
[ 99m Tc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Luis Coria-Domínguez, Paola Vallejo-Armenta, Myrna Luna-Gutiérrez, Blanca Ocampo-Garcia, Brenda Gibbens-Bandala, Francisco Osvaldo García-Pérez, Gerardo Ramírez-Nava, Clara Leticia Santos Cuevas, Guillermina Ferro-Flores
[ 99m Tc]Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)